GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM

N/A

Manufactured by Amerisourcebergen Drug Corporation

163 FDA adverse event reports analyzed

Last updated: 2026-04-15

About GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM

GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Amerisourcebergen Drug Corporation. The most commonly reported adverse reactions for GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM include DYSPNOEA, CONSTIPATION, COUGH, DEATH, FATIGUE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM.

Top Adverse Reactions

DYSPNOEA5 reports
CONSTIPATION4 reports
COUGH4 reports
DEATH4 reports
FATIGUE4 reports
NAUSEA4 reports
ACUTE KIDNEY INJURY3 reports
ANXIETY3 reports
HAEMORRHOIDS3 reports
PAIN3 reports
PNEUMONIA3 reports
ABDOMINAL DISTENSION2 reports
ANAEMIA2 reports
ASTHENIA2 reports
BACK PAIN2 reports
BALANCE DISORDER2 reports
BRONCHITIS2 reports
CHRONIC KIDNEY DISEASE2 reports
CYSTITIS2 reports
DEVICE OCCLUSION2 reports
DIARRHOEA2 reports
DIZZINESS2 reports
DRY MOUTH2 reports
ECONOMIC PROBLEM2 reports
EMOTIONAL DISTRESS2 reports
END STAGE RENAL DISEASE2 reports
FALL2 reports
GASTROOESOPHAGEAL REFLUX DISEASE2 reports
HAEMATURIA2 reports
INJECTION SITE ERYTHEMA2 reports
INJECTION SITE PAIN2 reports
INJURY2 reports
LOSS OF CONSCIOUSNESS2 reports
NASOPHARYNGITIS2 reports
PAIN IN EXTREMITY2 reports
PNEUMONIA ASPIRATION2 reports
PRODUCTIVE COUGH2 reports
RECTAL HAEMORRHAGE2 reports
RENAL CYST2 reports
RENAL FAILURE2 reports
RESPIRATORY TRACT CONGESTION2 reports
RESPIRATORY TRACT INFECTION2 reports
RETCHING2 reports
URINARY TRACT INFECTION2 reports
WEIGHT DECREASED2 reports
ABDOMINAL DISCOMFORT1 reports
ABDOMINAL PAIN1 reports
ACTIVITIES OF DAILY LIVING IMPAIRED1 reports
ADVERSE EVENT1 reports
AMNESIA1 reports
ANAPHYLACTIC REACTION1 reports
ANHEDONIA1 reports
AORTIC ARTERIOSCLEROSIS1 reports
AORTIC DISORDER1 reports
AORTIC VALVE INCOMPETENCE1 reports
APHAGIA1 reports
APHTHOUS STOMATITIS1 reports
ARTERIOSCLEROSIS CORONARY ARTERY1 reports
ARTHRALGIA1 reports
ASCITES1 reports
ASTHMA1 reports
ATELECTASIS1 reports
AZOTAEMIA1 reports
BASAL CELL CARCINOMA1 reports
BIOPSY GINGIVAL1 reports
BLADDER CANCER1 reports
BLOOD ACID PHOSPHATASE INCREASED1 reports
BLOOD PRESSURE ABNORMAL1 reports
BONE DISORDER1 reports
BRAIN MIDLINE SHIFT1 reports
BRAIN OEDEMA1 reports
CARCINOID TUMOUR1 reports
CARDIAC VALVE DISEASE1 reports
CARDIOMEGALY1 reports
CARPAL TUNNEL SYNDROME1 reports
CATARACT1 reports
CEREBROVASCULAR ACCIDENT1 reports
CHEST DISCOMFORT1 reports
CHEST PAIN1 reports
CHILLS1 reports
CHOKING1 reports
COLON CANCER1 reports
CONDITION AGGRAVATED1 reports
CONVULSION1 reports
CORONARY ARTERIAL STENT INSERTION1 reports
CORONARY ARTERY DISEASE1 reports
CORONARY ARTERY STENOSIS1 reports
COVID 191 reports
DECREASED APPETITE1 reports
DECUBITUS ULCER1 reports
DEEP VEIN THROMBOSIS1 reports
DEFORMITY1 reports
DEHYDRATION1 reports
DEPRESSION1 reports
DEVICE DISLOCATION1 reports
DEVICE INAPPROPRIATE SHOCK DELIVERY1 reports
DEVICE INFUSION ISSUE1 reports
DEVICE ISSUE1 reports
DEVICE KINK1 reports
DEVICE USE ISSUE1 reports

Report Outcomes

Out of 46 classified reports for GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM:

Serious 69.6%Non-Serious 30.4%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female24 (53.3%)
Male21 (46.7%)

Reports by Age

Age 763 reports
Age 392 reports
Age 452 reports
Age 602 reports
Age 642 reports
Age 381 reports
Age 431 reports
Age 491 reports
Age 501 reports
Age 531 reports
Age 541 reports
Age 621 reports
Age 631 reports
Age 651 reports
Age 661 reports
Age 711 reports
Age 721 reports
Age 731 reports
Age 801 reports
Age 821 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM?

This profile reflects 163 FDA FAERS reports that mention GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM?

Frequently reported terms in FAERS include DYSPNOEA, CONSTIPATION, COUGH, DEATH, FATIGUE, NAUSEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM?

Labeling and FAERS entries often list Amerisourcebergen Drug Corporation in connection with GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.